Australia markets closed

NeuroBo Pharmaceuticals, Inc. (NRBO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.9600-0.0600 (-1.49%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.9-0.88-4.16-3.13
Low estimate-1.02-1.11-5.47-4.96
High estimate-0.73-0.56-3.17-1.85
Year ago EPS-0.16-0.72-2.46-4.16
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.01-0.86-0.78-3.63
Actual EPS-0.16-0.72-2.28-1.32
Difference0.850.14-1.52.31
Surprise %84.20%16.30%-192.30%63.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.9-0.88-4.16-3.13
7 days ago-0.84-0.76-3.5-2.22
30 days ago-0.89-0.85-3.26-2.49
60 days ago-0.89-0.85-3.26-2.49
90 days ago-0.89-0.85-3.26-2.49
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNRBOIndustrySector(s)S&P 500
Current qtr.-462.50%N/AN/AN/A
Next qtr.-22.20%N/AN/AN/A
Current year-69.10%N/AN/AN/A
Next year24.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A